Dr. Caudle on Upcoming Breast Cancer Trial Results

Abigail S. Caudle, MD, Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, gives an overview of two trials in breast cancer.

Caudle first highlights the ACOSOG Z1071 trial, which aimed to analyze the false-negative rate of a sentinel lymph node dissection after neoadjuvant chemotherapy. This trial closed early with higher than expected accrual, demonstrating physicians' interest.

evaluating the effect of chemotherapy in patients with breast cancer who have a low to intermediate recurrence score.

Further, Caudle is excited to see how the results of the SWOG RxPONDER trial could benefit patients. This trial is